Mannkind (MNKD) Operating Expenses (2010 - 2026)
Mannkind (MNKD) reported Operating Expenses of $91.8 million for Q1 2026, up 63.82% year-over-year from $56.1 million in Q1 2025, and down 23.24% on a QoQ basis from $119.6 million in Q4 2025.
Mannkind (MNKD) has 17 years of Operating Expenses data on file, last reported at $91.8 million in Q1 2026.
- Quarterly Operating Expenses rose 63.82% year-over-year to $91.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $345.9 million (up 57.65% YoY) and the FY2025 annual result came in at $310.2 million, up 45.67% from the prior year.
- Operating Expenses slipped to $91.8 million in Q1 2026 per MNKD's latest filing, from $119.6 million in the prior quarter.
- Across five years, Operating Expenses topped out at $119.6 million in Q4 2025 and bottomed at $33.2 million in Q1 2022.
- The 5-year median for Operating Expenses is $50.3 million (2024), against an average of $57.0 million.
- The widest annual swing landed in 2024, when Operating Expenses fell 0.66%; it then soared 137.95% in 2025.
- Tracing MNKD's Operating Expenses over 5 years: stood at $48.8 million in 2022, then advanced by 3.61% to $50.6 million in 2023, then fell by 0.66% to $50.3 million in 2024, then soared by 137.95% to $119.6 million in 2025, then slipped by 23.24% to $91.8 million in 2026.
- Per Business Quant, the three latest MNKD Operating Expenses figures stand at $91.8 million (Q1 2026), $119.6 million (Q4 2025), and $63.2 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Opex (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 2.97 Mn |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | 4.33 Mn |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | -138.30 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 15.76 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 1.85 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | -3.82 Mn |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 2.96 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 898.54 Mn |
| 10 | Mannkind | 1.09 Bn | 956.66 Mn | 82.66 Mn | 91.84 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 91.84 Mn |
| Dec 31, 2025 | 119.64 Mn |
| Sep 30, 2025 | 63.23 Mn |
| Jun 30, 2025 | 71.23 Mn |
| Mar 31, 2025 | 56.06 Mn |
| Dec 31, 2024 | 50.28 Mn |
| Sep 30, 2024 | 57.32 Mn |
| Jun 30, 2024 | 55.78 Mn |
| Mar 31, 2024 | 49.54 Mn |
| Dec 31, 2023 | 50.61 Mn |
| Sep 30, 2023 | 46.16 Mn |
| Jun 30, 2023 | 46.89 Mn |
| Mar 31, 2023 | 46.62 Mn |
| Dec 31, 2022 | 48.85 Mn |
| Sep 30, 2022 | 42.44 Mn |
| Jun 30, 2022 | 39.35 Mn |
| Mar 31, 2022 | 33.25 Mn |
| Dec 31, 2021 | 36.48 Mn |
| Sep 30, 2021 | 28.80 Mn |
| Jun 30, 2021 | 33.55 Mn |
| Mar 31, 2021 | 23.63 Mn |
| Dec 31, 2020 | 42.19 Mn |
| Sep 30, 2020 | 24.48 Mn |
| Jun 30, 2020 | 23.03 Mn |
| Mar 31, 2020 | 23.36 Mn |
| Dec 31, 2019 | 27.35 Mn |
| Sep 30, 2019 | 23.37 Mn |
| Jun 30, 2019 | 25.95 Mn |
| Mar 31, 2019 | 30.96 Mn |
| Dec 31, 2018 | 23.76 Mn |
| Sep 30, 2018 | 26.01 Mn |
| Jun 30, 2018 | 24.43 Mn |
| Mar 31, 2018 | 30.25 Mn |
| Dec 31, 2017 | 33.37 Mn |
| Sep 30, 2017 | 30.22 Mn |
| Jun 30, 2017 | 33.73 Mn |
| Mar 31, 2017 | 22.61 Mn |
| Dec 31, 2016 | 24.24 Mn |
| Sep 30, 2016 | 44.13 Mn |
| Jun 30, 2016 | 19.12 Mn |
| Mar 31, 2016 | 20.01 Mn |
| Dec 31, 2015 | 272.86 Mn |
| Sep 30, 2015 | 26.00 Mn |
| Jun 30, 2015 | 24.05 Mn |
| Mar 31, 2015 | 21.74 Mn |
| Dec 31, 2014 | 30.10 Mn |
| Sep 30, 2014 | 38.27 Mn |
| Jun 30, 2014 | 69.85 Mn |
| Mar 31, 2014 | 41.41 Mn |
| Dec 31, 2013 | 46.62 Mn |
| Sep 30, 2013 | 44.76 Mn |
| Jun 30, 2013 | 41.59 Mn |
| Mar 31, 2013 | 36.44 Mn |
| Dec 31, 2012 | 33.49 Mn |
| Sep 30, 2012 | 35.52 Mn |
| Jun 30, 2012 | 44.05 Mn |
| Mar 31, 2012 | 33.93 Mn |
| Dec 31, 2011 | 30.58 Mn |
| Sep 30, 2011 | 32.77 Mn |
| Jun 30, 2011 | 39.19 Mn |
| Mar 31, 2011 | 38.05 Mn |
| Dec 31, 2010 | 32.09 Mn |
| Sep 30, 2010 | 42.54 Mn |
| Jun 30, 2010 | 37.36 Mn |